Phase 2 Bladder Cancer Trial, Recruiting NCT06972615 Sponsor: BLATAM Condition: Bladder Cancer
Back to Bladder Cancer

Phase 2 Bladder Cancer Trial, Recruiting

NCT06972615
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to sign a consent form agreeing to take part in the trial.
  • You are 18 years of age or older at the time of signing the consent form.
  • You have been diagnosed with a specific type of bladder cancer (called transitional cell carcinoma) that is high-risk and has not grown into the muscle of the bladder wall — confirmed by a laboratory test on a tissue sample.
  • If you had raised/lumpy tumors (called papillary tumors), a procedure to remove all visible tumors from your bladder (called TURBT) has already been completed.
  • You have already received a full course of BCG treatment (a common bladder cancer therapy given directly into the bladder) but your bladder cancer has either not responded to it, come back, or persisted within certain time periods as defined by the trial (confirm with trial site for exact details).

Who may not be able to join:

  • Your bladder cancer has grown into or through the bladder muscle, or has spread to other parts of the body.
  • You have the same type of cancer present in other parts of your urinary tract (such as the urethra, ureters, or kidneys) at the same time.
  • You are currently taking part in another clinical trial or have received an experimental treatment within the last 4 weeks.
  • You have received any treatment given directly into the bladder (chemotherapy or immunotherapy) between your most recent bladder procedure and the start of this trial (a single dose given during that procedure may be acceptable — confirm with trial site).
  • You have had chemotherapy, targeted drug therapy, or radiation therapy within the 2 weeks before starting this trial, or you are still experiencing side effects from a previous treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +541156164207

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
BLATAM
Registry
ClinicalTrials.gov
Start date
21 May 2026
Est. completion
31 December 2029

Where this trial is recruiting

🇦🇷 Argentina

Primary endpoints

eficacy; Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov